Identificação
Identificação pessoal
- Nome completo
- Carsten Ehrhardt
Nomes de citação
- Ehrhardt, Carsten
Identificadores de autor
- Ciência ID
- AB10-196F-2313
- ORCID iD
- 0000-0003-0730-1829
Formação
Grau | Classificação | |
---|---|---|
2000/01/04 - 2003/03/26
Concluído
|
Department of Biopharmaceutics and Pharmaceutical Technology, Doctor rerum naturalium (Doctor)
Universität des Saarlandes, Alemanha
|
summa cum laude |
Percurso profissional
Ciência
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2008/10 - 2012/07 | Gestão de Ciência e Tecnologia | Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda |
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda | ||
2003/09 - 2006/09 | Investigador Coordenador (carreira) (Investigação) | Universität des Saarlandes, Alemanha |
Universität des Saarlandes, Alemanha | ||
2003/03 - 2003/09 | Pós-doutorado (Investigação) | Universität des Saarlandes, Alemanha |
Universität des Saarlandes, Alemanha | ||
2000/01 - 2003/03 | Assistente de Investigação (carreira) (Investigação) | Universität des Saarlandes, Alemanha |
Universität des Saarlandes, Alemanha |
Docência no Ensino Superior
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2017/10 - Atual | Professor Catedrático (Docente Universitário) | Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda |
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda | ||
2017/07 - 2022/06 | Professor Associado Convidado (Docente Universitário) | University of Southern California Department of Pharmacology and Pharmaceutical Sciences, Estados Unidos |
University of Southern California Department of Pharmacology and Pharmaceutical Sciences, Estados Unidos | ||
2011/08 - 2017/09 | Professor Associado (Docente Universitário) | Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda |
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda | ||
2008/02 - 2017/01 | Professor Associado Convidado (Docente Universitário) | University of Southern California Department of Pharmacology and Pharmaceutical Sciences, Estados Unidos |
University of Southern California Department of Pharmacology and Pharmaceutical Sciences, Estados Unidos | ||
2010/03 - 2014/07 | Professor Catedrático Convidado (Docente Universitário) | Université Claude Bernard Lyon 1 Institut des Sciences Pharmaceutiques et Biologiques Faculté de Pharmacie de Lyon, França |
Université Claude Bernard Lyon 1 Institut des Sciences Pharmaceutiques et Biologiques Faculté de Pharmacie de Lyon, França | ||
2008/10 - 2011/08 | Leitor (Docente Universitário) | Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda |
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda | ||
2004/08 - 2008/09 | Leitor (Docente Universitário) | Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda |
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda |
Projetos
Bolsa
Designação | Financiadores | |
---|---|---|
2022/09 - Atual | Development of ergothioneine-containing liposomes for aerosol therapy of chronic obstructive pulmonary disease
Investigador responsável
|
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences
Em curso
|
2023/08 - 2026/08 | Studying the influence of organic cation transporters on the pulmonary disposition of inhaled drugs with PET imaging in rats
P36738
Co-Investigador Responsável (Co-IR)
|
Fonds zur Förderung der wissenschaftlichen Forschung |
2022/09 - 2026/08 | STOP SPREAD BAD BUGS
101073263
Co-Investigador Responsável (Co-IR)
|
European Commission Marie Sklodowska-Curie Actions |
2021/09 - 2025/08 | Mechanistic and targeting studies on orellanine as a potential treatment of clear cell renal cell carcinoma
-
Co-Investigador Responsável (Co-IR)
|
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences |
2021/01 - 2022/12 | Evaluation of the impact of membrane efflux transporters in the selective lung distribution of inhaled drugs
IP/2020/0959
Investigador responsável
|
Enterprise Ireland |
2019/02 - 2022/03 | Establishment and validation of an isolated and perfused porcine lung model for inhalation biopharmaceutical investigations
IP/2019/0797
Investigador responsável
|
Enterprise Ireland |
2020/02 - 2021/08 | Effect of tobacco smoke on the locations of vitamin C carrier proteins in chronic obstructive lung disease
TSA-2020-34968, TRY 39,400
Co-Investigador Responsável (Co-IR)
|
Istanbul Teknik Üniversitesi Bilimsel Arastirma Projeleri Koordinasyon Birimi |
2018/09 - 2021/08 | PET/MR imaging to assess the role of membrane transporters in pulmonary disposition of inhaled drugs
LSC17-009
Co-Investigador Responsável (Co-IR)
|
|
2018/01 - 2020/12 | Development of a Biopharmaceutics Classification System for Inhalation Based Drug Products (iBCS)
-
Co-Investigador Responsável (Co-IR)
|
Product Quality Research Institute |
2015/09 - 2018/08 | Mesenchymal stem cells in emphysema: finding the right niche for alveolar repair
-
Co-Investigador Responsável (Co-IR)
|
Longfonds |
2015/09 - 2018/08 | Development of broad-spectrum anti-viral agents
DKK6,500,000
Co-Investigador Responsável (Co-IR)
|
Danmarks Frie Forskningsfond |
2014/09 - 2018/08 | Drug transporter effects in smoke-related lung diseases
-
Investigador responsável
|
Republic of Iraq Ministry of Higher Education and Scientific Research |
2014/07 - 2018/06 | Role of OCTN1 in tobacco-related COPD
-
Investigador responsável
|
Flight Attendant Medical Research Institute |
2015/04 - 2016/09 | Role of vitamin C transporters in tobacco-related chronic obstructive pulmonary disease
3001 Project Grant 115S156, TRY 86,855
Co-Investigador Responsável (Co-IR)
|
Türkiye Bilimsel ve Teknolojik Arastirma Kurumu |
2014/07 - 2015/06 | Formulation and characterisation of Trojan systems for inhalation therapy based on budesonide containing nanoparticles
-
Investigador responsável
|
Ministério da Educação |
2012/07 - 2015/06 | Modeling of COPD by novel RAGE transgenic mice
-
Co-Investigador Responsável (Co-IR)
|
Flight Attendant Medical Research Institute |
2013/12 - 2014/11 | Establishment of NCI-H441 cells as an in vitro model for pulmonary drug disposition studies
-
Investigador responsável
|
Chiesi Farmaceutici SpA |
2011/12 - 2014/04 | Characterisation of absorption pathways of CPZEN-45 across respiratory epithelial barrier
-
Investigador responsável
|
Access to Advanced Health Institute |
2007/12 - 2012/12 | Oesophageal cancer - towards new therapies
TRA/2007/11
Co-Investigador Responsável (Co-IR)
|
Health Research Board |
2009/10 - 2012/09 | Functional expression of the key ion channels within different alveolar epithelial cell types
-
Investigador responsável
|
Irish Research Council |
2007/10 - 2010/09 | Role of PKC in inflammatory processes in the lung and bowel diseases
-
Investigador responsável
|
Irish Research Council |
2006/05 - 2010/04 | Nanopharmacology in platelet research: focus on nitric oxide and matrix metalloproteinases
-
Co-Investigador Responsável (Co-IR)
|
Science Foundation Ireland |
2007/10 - 2008/10 | Liposomal drug carrier systems for inhalation chemotherapy of lung cancer
PC/2007/081
Investigador responsável
|
Enterprise Ireland |
2004/10 - 2008/09 | Galenos Euro-PhD: Towards a European PhD in Advanced Drug Delivery
-
Investigador responsável
|
|
2007/06 - 2007/09 | Development of a spray-dried instant liposome formulation
-
Investigador responsável
|
|
2006/10 - 2007/09 | Establishment of a primary culture of human alveolar epithelial cells
-
Investigador responsável
|
The University of Dublin Trinity College |
2007/07 - 2007/07 | Development and characterisation of biopharmaceutical models for practised and novel drug delivery routes
-
Investigador responsável
|
Pfizer Inc |
2006/01 - 2006/07 | Studies on absorption of salbutamol across the respiratory epithelium
-
Investigador responsável
|
Sumitomo Pharma America Inc |
2002/08 - 2005/07 | Development characterisation of an in vitro model based on human cornea and conjunctiva epithelial cells
-
Co-Investigador Responsável (Co-IR)
|
Ursapharm Arzneimittel GmbH |
2004/02 - 2004/09 | Absorption mechanisms and pathways for serum proteins and peptide drugs via pulmonary alveolar epithelium cells
-
Investigador responsável
|
Novo Nordisk A/S Global Research |
2002/06 - 2004/05 | Assessment of telomerase inhibitors for the inhalation treatment of lung cancer
-
Co-Investigador Responsável (Co-IR)
|
Deutsche Hautkrebs-Stiftung |
2000/01 - 2002/08 | Establishment and characterisation of in vitro models for the assessment of pulmonary drug absorption
-
Co-Investigador Responsável (Co-IR)
|
Bundesinstitut für Risikobewertung |
Produções
Publicações
Artigo em revista |
|
Atividades
Orientação
Título / Tema Papel desempenhado |
Curso (Tipo) Instituição / Organização |
|
---|---|---|
2019/03 - 2023 | Exploring membrane transporters in lung epithelial cells: drug-transporter interaction analyses in different in vitro models
Orientador
|
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda
|
2014/09 - 2018/09 | The role of drug transporters in chronic obstructive pulmonary disease
Orientador
|
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda
|
2014/09 - 2018/09 | Characterisation of the functional role of OCTN1 in the pathogenesis of COPD
Orientador
|
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda
|
2012/04 - 2016/08 | Desenvolvimento de sistemas particulados contendo fármacos para administração pulmonar preparados por spray-drying
Coorientador
|
Universidade Federal do Rio Grande do Sul, Brasil
|
2008/04 - 2013/04 | Investigation of novel photosensitisers for photodynamic cancer therapy
Coorientador
|
Trinity College Dublin School of Chemistry, Irlanda
|
2009/04 - 2012/10 | Functional expression of the epithelial sodium channel d-subunit in human respiratory epithelial cells
Orientador
|
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda
|
2009/03 - 2012/10 | Drug transport across the human respiratory epithelial cell barrier
Orientador
|
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda
|
2008/08 - 2011/12 | Liposomes as carriers for systemic delivery of salmon calcitonin by inhalation
Orientador
|
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda
|
2007/10 - 2010/09 | Optimisation of pulmonary drug delivery of the model peptide drug salmon calcitonin
Orientador
|
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda
|
2007/10 - 2010/09 | Cytokine-induced epithelial-mesenchymal transition: mechanisms and implications for fibrotic diseases of respiratory and intestinal
epithelia
Orientador
|
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda
|
2005/10 - 2010/01 | Characterisation of drug transporters in human respiratory epithelial cells
Orientador
|
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda
|
2004/10 - 2009/10 | In vitro investigation of the potential anti-inflammatory properties of novel compounds with respect to LFA-1 mediated T cell
motility and cytotoxicity profiling
Coorientador
|
Trinity College Dublin School of Pharmacy and Pharmaceutical Sciences, Irlanda
|
2002/08 - 2006/12 | Examination of the penetration behaviour of pharmaceuticals in the eye and establishment of an in vitro cell culture model
for ocular drug delivery
Orientador
|
Universität des Saarlandes, Alemanha
|
2002/08 - 2006/09 | Liposomal drug carrier systems for inhalation treatment of lung cancer
Orientador
|
Universität des Saarlandes, Alemanha
|